Oct 27, 2025 07:00AM DiagnaMed and QIMC Confirm Major Expansion of Hydrogen Zone by Over 11 Kilometers in Ontario's Temiscamingue Graben

Oct 14, 2025 07:00AM DiagnaMed and QIMC Confirm Major Discovery of Widespread Natural Hydrogen System in Ontario's Temiscamingue Graben

Oct 14, 2025 07:00AM QIMC and DiagnaMed Confirm Major Discovery of Widespread Natural Hydrogen System in Ontario's Témiscamingue Graben

Oct 8, 2025 12:30PM DiagnaMed Holdings Corp. and Quebec Innovative Materials Corp. Sign Memorandum of Understanding with Temiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydroge

Oct 8, 2025 12:30PM Quebec Innovative Materials Corp. and DiagnaMed Holdings Corp. Sign Memorandum of Understanding with Témiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydrog

Sep 30, 2025 07:00AM DiagnaMed Strengthens Leadership Team and Confirms Completion of Extensive Hydrogen Soil Sampling Program in Ontario's Temiscamingue Graben

Jul 24, 2025 07:30AM DiagnaMed Congratulates QIMC on Quebec Drill Permit Approval and Announces Significant Progress on Ontario Clean Natural Hydrogen Soil Sampling Program

Jul 21, 2025 08:16PM DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants

Jul 16, 2025 07:32AM DiagnaMed appoints Edward Low as interim CFO after Jing Peng steps down

Jul 16, 2025 07:30AM DiagnaMed Announces Chief Financial Officer Transition

Jul 3, 2025 08:00AM QIMC-Led Hydrogen Exploration Initiative Expands into Ontario Through Strategic Partnership with DiagnaMed and INRS for Natural Hydrogen Development

Jul 3, 2025 07:30AM DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board

Jun 17, 2025 07:30AM DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben

Jun 12, 2025 08:00AM QIMC and DiagnaMed Strengthen Strategic Partnership; John Karagiannidis Joins as President, CEO, and Director of DiagnaMed

Apr 14, 2025 08:00AM DiagnaMed Announces Closing of LIFE Offering

Mar 3, 2025 08:00AM DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis

Feb 27, 2025 05:00PM DiagnaMed Announces LIFE Offering of up to $510,000

Feb 27, 2025 08:00AM DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC

Jan 8, 2025 08:00AM QIMC and DiagnaMed to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project